Compare ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund vs UTI Healthcare Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
UTI Healthcare Fund
Risk
Very High
Very High
Rating
5.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.09
2.22
NAV
₹47.50
₹380.43
Fund Started
25 Jun 2018
01 Aug 2005
Fund Size
₹6624.58 Cr
₹1307.98 Cr
Exit Load
Exit load of 1% if redeemed within 15 days.
Exit load of 1% if redeemed within 30 days.
1 Year
5.43%
11.46%
3 Year
23.11%
23.21%
5 Year
15.81%
14.66%
Equity
96.05%
95.05%
Cash
3.95%
4.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Sun Pharmaceutical Industries Ltd. | 8.54% |
Ajanta Pharma Ltd. | 5.08% |
Divi's Laboratories Ltd. | 4.74% |
Gland Pharma Ltd. | 4.11% |
Caplin Point Laboratories Ltd. | 4.02% |
Lupin Ltd. | 3.77% |
Apollo Hospitals Enterprise Ltd. | 3.52% |
Alkem Laboratories Ltd. | 3.14% |
Dr. Reddy's Laboratories Ltd. | 3.01% |
Max Healthcare Institute Ltd. | 2.98% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
25 Jun 2018
01 Aug 2005
